- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.09. | Ocumetics Technology Corp: Ocumetics's Group One lens patients reach 12 months | 3 | Stockwatch | ||
| 17.09. | Ocumetics Technology Corp.: Ocumetics Provides Summary of Group One Patient Clinical Progress | 1 | TheNewswire | ||
| OCUMETICS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 09.09. | Ocumetics Technology Corp: Ocumetics begins patient recruitment in Mexico City | 1 | Stockwatch | ||
| 08.09. | Ocumetics Technology Corp.: Ocumetics Announces Initiation of Patient Recruitment for Upcoming Group Two Human Clinical Surgeries | 3 | TheNewswire | ||
| 01.09. | Ocumetics Technology Corp: Ocumetics completes manufacturing of next-gen lenses | 1 | Stockwatch | ||
| 31.08. | Ocumetics Technology Corp.: Ocumetics Completes Manufacturing of Next Generation Solid State Accommodating Intraocular Lenses for Upcoming Group Two First in Human Clinical Surgeries | 2 | TheNewswire | ||
| 28.08. | Ocumetics Technology Corp: Ocumetics Technology 7,775,325-share private placement | 1 | Stockwatch | ||
| 25.08. | Ocumetics Technology Corp: Ocumetics completes final tranche of placement | 1 | Stockwatch | ||
| 24.08. | Ocumetics Technology Corp.: Ocumetics Announces Completion of Third and Final Tranche of Unit Private Placement | 1 | TheNewswire | ||
| 31.07. | Ocumetics Technology Corp: Ocumetics closes $2.5M second tranche of placement | 1 | Stockwatch | ||
| 31.07. | Ocumetics Technology Corp.: Ocumetics Announces Completion of Second Tranche of Unit Private Placement | 1 | TheNewswire | ||
| 31.07. | Ocumetics Technology Corp: Ocumetics increases private placement to $3.2-million | 1 | Stockwatch | ||
| 30.07. | Ocumetics Technology Corp.: Ocumetics Announces Upsizing of Unit Private Placement | 1 | TheNewswire | ||
| 30.07. | Ocumetics expands unit offering to C$3.2M | 1 | Seeking Alpha | ||
| 30.07. | Ocumetics Technology Corp: Ocumetics closes $448,130 first tranche of placement | 1 | Stockwatch | ||
| 29.07. | Ocumetics Technology Corp.: Ocumetics Announces Completion of First Tranche of Unit Private Placement | 1 | TheNewswire | ||
| 10.07. | Ocumetics Technology Corp: Ocumetics working on placement to develop clinical | 5 | Stockwatch | ||
| 09.07. | Ocumetics Technology Corp.: Ocumetics Announces Corporate and Operational Update as Positive Six-Month Clinical Results Advance Next Phase of First-in-Human Study | 1 | TheNewswire | ||
| 08.07. | Ocumetics Technology Corp: Ocumetics arranges $2-million private placement | 1 | Stockwatch | ||
| 07.07. | Ocumetics Technology Corp.: Ocumetics Announces Offering of Units | 2 | TheNewswire |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | ||
| HEARTFLOW | 47,590 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| FRESENIUS | 42,425 | +2,01 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| FRESENIUS MEDICAL CARE | 37,480 | +2,07 % | Fresenius Medical Care: Helen Giza verlässt den Konzern - Nachfolger steht fest | Bad Marienberg (www.anleihencheck.de) - Ad hoc-Mitteilung der Fresenius Medical Care AG vom 07.10.2026:Der Aufsichtsrat der Fresenius Medical Care AG hat heute einstimmig beschlossen, Shervin J. Korangy... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,235 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| BETA BIONICS | 17,440 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| CONCENTRA GROUP | 36,670 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning | ||
| SIEMENS HEALTHINEERS | 38,710 | +1,18 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |
Das Unternehmen OCUMETICS TECHNOLOGY CORP kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,214 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OCUMETICS TECHNOLOGY CORP finden Sie auf Wallstreet Online.